AHPA opposes U.S. Customs proposal to reclassify certain bilberry and blueberry extracts

AHPA Alerts

AHPA Alerts

AHPA keeps members and the industry informed of recent news and developments that impact the trade through email alerts. Subscribe to news as it happens or a weekly summary of all alerts.

Subscribe

View recent alerts:

  • Legal Alerts News on dietary supplement laws, regulations and enforcement
  • Science Alerts The latest research on herbs and botanicals
  • Market Alerts Herbal market trends and AHPA-member press releases
  • Media Alerts Media coverage of the herbal industry 
  • Cannabis Alerts The latest research and news about hemp, CBD and medical marijuana
  • Cosmetic Alerts Regulatory updates and personal care product news

Subscribe to AHPA Updates to stay informed about the latest AHPA news and resources.

Recent News

AHPA opposes U.S. Customs proposal to reclassify certain bilberry and blueberry extracts

January 2016: AHPA Update

Published: Wednesday, January 27, 2016

AHPA works to maintain appropriate tariff classifications for botanical extracts

In comments submitted on January 22, 2016 the American Herbal Products Association (AHPA) expressed opposition to recent U.S. Customs and Border Protection (CBP) proposals that would change the tariff classification of certain bilberry and blueberry extract powders.

AHPA comments were in response to a December 23, 2015 CBP notice of proposals to revoke three ruling letters, modify two ruling letters and change the tariff classification of these extracts. Numerous AHPA members could be affected by this proposed change, and AHPA expressed opposition to the proposal as part of its goal to maintain appropriate tariff classifications for botanical extracts.

“AHPA views CBP’s proposal as directly problematic for importers and marketers of bilberry and blueberry extracts and as presenting potential economic burdens on companies that trade in other herbal extracts,” said AHPA President Michael McGuffin. “If this particular CBP proposal becomes the norm we could see inappropriate tariffs applied to many other ingredients derived from botanical sources.”

AHPA’s comments provided informed insights into how botanical extracts are manufactured, discussed numerous relevant CBP ruling precedents, and encouraged CBP to use the word “extract” in a manner that is consistent with common usage of the word by industry. The comments also expressed AHPA’s views that CBP should not automatically classify an extract in a higher tariff category based solely on use of processing such as standardization, purification or enrichment with such technologies as column chromatography.


Download AHPA's comments >>

Print

2022 Annual Fund Sponsors

AHPA appreciates the support of its sponsors, but does not endorse, recommend, or provide a warranty for any sponsor company, its products or services. AHPA has no responsibility for any transaction entered into with any of these companies.